akash.verma@cenmed.com
(732) 447-1115-
E414498-50mgInformationElimusertib (BAY-1895344) is a very potent and highly selectiveATR (ataxia telangiectasia and Rad3-related)inhibitor with IC50 of 7 nM. Elimusertib potently inhibits proliferation of a broad spectrum of human tumor cell lines with median -
E414498-25mgInformationElimusertib (BAY-1895344) is a very potent and highly selectiveATR (ataxia telangiectasia and Rad3-related)inhibitor with IC50 of 7 nM. Elimusertib potently inhibits proliferation of a broad spectrum of human tumor cell lines with median -
E414498-10mgInformationElimusertib (BAY-1895344) is a very potent and highly selectiveATR (ataxia telangiectasia and Rad3-related)inhibitor with IC50 of 7 nM. Elimusertib potently inhibits proliferation of a broad spectrum of human tumor cell lines with median -
E414498-100mgInformationElimusertib (BAY-1895344) is a very potent and highly selectiveATR (ataxia telangiectasia and Rad3-related)inhibitor with IC50 of 7 nM. Elimusertib potently inhibits proliferation of a broad spectrum of human tumor cell lines with median -
E414221-5mgInformationElexacaftor (VX-445) Elexacaftor (VX-445) is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector. This is a compound which is not chiral purity.TargetsCFTR. -
E414221-50mgInformationElexacaftor (VX-445) Elexacaftor (VX-445) is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector. This is a compound which is not chiral purity.TargetsCFTR. -
E414221-25mgInformationElexacaftor (VX-445) Elexacaftor (VX-445) is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector. This is a compound which is not chiral purity.TargetsCFTR. -
E414221-1mgInformationElexacaftor (VX-445) Elexacaftor (VX-445) is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector. This is a compound which is not chiral purity.TargetsCFTR. -
E414221-10mgInformationElexacaftor (VX-445) Elexacaftor (VX-445) is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector. This is a compound which is not chiral purity.TargetsCFTR. -
E413638-5mgInformationELN484228 is a cell-permeable blocker that targetsα-synuclein, a key protein in Parkinson’s disease. -
E413638-50mgInformationELN484228 is a cell-permeable blocker that targetsα-synuclein, a key protein in Parkinson’s disease. -
E413638-25mgInformationELN484228 is a cell-permeable blocker that targetsα-synuclein, a key protein in Parkinson’s disease.
